Literature DB >> 27035620

Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer.

M Hornsveld1, M Tenhagen2, R A van de Ven2, A M M Smits1, M H van Triest1, M van Amersfoort2, D E A Kloet1, T B Dansen1, B M Burgering1, P W B Derksen2.   

Abstract

Loss of cellular adhesion leads to the progression of breast cancer through acquisition of anchorage independence, also known as resistance to anoikis. Although inactivation of E-cadherin is essential for acquisition of anoikis resistance, it has remained unclear how metastatic breast cancer cells counterbalance the induction of apoptosis without E-cadherin-dependent cellular adhesion. We report here that E-cadherin inactivation in breast cancer cells induces PI3K/AKT-dependent FOXO3 inhibition and identify FOXO3 as a novel and direct transcriptional activator of the pro-apoptotic protein BMF. As a result, E-cadherin-negative breast fail to upregulate BMF upon transfer to anchorage independence, leading to anoikis resistance. Conversely, expression of BMF in E-cadherin-negative metastatic breast cancer cells is sufficient to inhibit tumour growth and dissemination in mice. In conclusion, we have identified repression of BMF as a major cue that underpins anoikis resistance and tumour dissemination in E-cadherin-deficient metastatic breast cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27035620      PMCID: PMC5072425          DOI: 10.1038/cdd.2016.33

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  52 in total

1.  FOXO3 selectively amplifies enhancer activity to establish target gene regulation.

Authors:  Astrid Eijkelenboom; Michal Mokry; Lydia M Smits; Edward E Nieuwenhuis; Boudewijn M T Burgering
Journal:  Cell Rep       Date:  2013-12-19       Impact factor: 9.423

2.  BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms.

Authors:  Arnaud A Mailleux; Michael Overholtzer; Tobias Schmelzle; Philippe Bouillet; Andreas Strasser; Joan S Brugge
Journal:  Dev Cell       Date:  2007-02       Impact factor: 12.270

3.  Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.

Authors:  Samantha R Oakes; François Vaillant; Elgene Lim; Lily Lee; Kelsey Breslin; Frank Feleppa; Siddhartha Deb; Matthew E Ritchie; Elena Takano; Teresa Ward; Stephen B Fox; Daniele Generali; Gordon K Smyth; Andreas Strasser; David C S Huang; Jane E Visvader; Geoffrey J Lindeman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

4.  The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.

Authors:  Kristen L Meerbrey; Guang Hu; Jessica D Kessler; Kevin Roarty; Mamie Z Li; Justin E Fang; Jason I Herschkowitz; Anna E Burrows; Alberto Ciccia; Tingting Sun; Earlene M Schmitt; Ronald J Bernardi; Xiaoyong Fu; Christopher S Bland; Thomas A Cooper; Rachel Schiff; Jeffrey M Rosen; Thomas F Westbrook; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-09       Impact factor: 11.205

5.  E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.

Authors:  Xiaolan Qian; Tatiana Karpova; Allan M Sheppard; James McNally; Douglas R Lowy
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

6.  Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils.

Authors:  Shyra J Gardai; David A Hildeman; Steve K Frankel; Ben B Whitlock; S Courtney Frasch; Niels Borregaard; Philippa Marrack; Donna L Bratton; Peter M Henson
Journal:  J Biol Chem       Date:  2004-02-06       Impact factor: 5.157

7.  The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53.

Authors:  Steven N Reuland; Nathaniel B Goldstein; Katie A Partyka; David A Cooper; Mayumi Fujita; David A Norris; Yiqun G Shellman
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

Review 8.  Integrins, oncogenes, and anchorage independence.

Authors:  M A Schwartz
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

9.  Genome-wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling.

Authors:  Astrid Eijkelenboom; Michal Mokry; Elzo de Wit; Lydia M Smits; Paulien E Polderman; Miranda H van Triest; Ruben van Boxtel; Almut Schulze; Wouter de Laat; Edwin Cuppen; Boudewijn M T Burgering
Journal:  Mol Syst Biol       Date:  2013       Impact factor: 11.429

10.  A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation.

Authors:  Michael L van de Weijer; Michael C Bassik; Rutger D Luteijn; Cornelia M Voorburg; Mirjam A M Lohuis; Elisabeth Kremmer; Rob C Hoeben; Emily M LeProust; Siyuan Chen; Hanneke Hoelen; Maaike E Ressing; Weronika Patena; Jonathan S Weissman; Michael T McManus; Emmanuel J H J Wiertz; Robert Jan Lebbink
Journal:  Nat Commun       Date:  2014-05-08       Impact factor: 14.919

View more
  18 in total

1.  Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.

Authors:  Xiaolong Alan Zhou; Abner Louissaint; Alexander Wenzel; Jingyi Yang; Maria Estela Martinez-Escala; Andrea P Moy; Elizabeth A Morgan; Christian N Paxton; Bo Hong; Erica F Andersen; Joan Guitart; Amir Behdad; Lorenzo Cerroni; David M Weinstock; Jaehyuk Choi
Journal:  J Invest Dermatol       Date:  2018-05-30       Impact factor: 8.551

2.  Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells.

Authors:  Cathinka Boedicker; Michelle Hussong; Christina Grimm; Nadezda Dolgikh; Michael T Meister; Julius C Enßle; Marek Wanior; Stefan Knapp; Michal R Schweiger; Simone Fulda
Journal:  Oncogene       Date:  2020-03-11       Impact factor: 9.867

Review 3.  Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer.

Authors:  Heather C Bruner; Patrick W B Derksen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

4.  Dynein light chain binding determines complex formation and posttranslational stability of the Bcl-2 family members Bmf and Bim.

Authors:  Prafull Kumar Singh; Aristomenis Roukounakis; Arnim Weber; Kushal Kumar Das; Benedicte Sohm; Andreas Villunger; Ana J Garcia-Saez; Georg Häcker
Journal:  Cell Death Differ       Date:  2019-06-12       Impact factor: 15.828

5.  MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.

Authors:  Fiona C Brown; Eric Still; Richard P Koche; Christina Y Yim; Sumiko Takao; Paolo Cifani; Casie Reed; Shehana Gunasekera; Scott B Ficarro; Peter Romanienko; Willie Mark; Craig McCarthy; Elisa de Stanchina; Mithat Gonen; Venkatraman Seshan; Patrick Bhola; Conor O'Donnell; Barbara Spitzer; Crystal Stutzke; Vincent-Philippe Lavallée; Josée Hébert; Andrei V Krivtsov; Ari Melnick; Elisabeth M Paietta; Martin S Tallman; Anthony Letai; Guy Sauvageau; Gayle Pouliot; Ross Levine; Jarrod A Marto; Scott A Armstrong; Alex Kentsis
Journal:  Cancer Discov       Date:  2018-02-05       Impact factor: 39.397

6.  Variants in members of the cadherin-catenin complex, CDH1 and CTNND1, cause blepharocheilodontic syndrome.

Authors:  Anneke Kievit; Federico Tessadori; Hannie Douben; Ingrid Jordens; Madelon Maurice; Jeannette Hoogeboom; Raoul Hennekam; Sheela Nampoothiri; Hülya Kayserili; Marco Castori; Margo Whiteford; Connie Motter; Catherine Melver; Michael Cunningham; Anne Hing; Nancy M Kokitsu-Nakata; Siulan Vendramini-Pittoli; Antonio Richieri-Costa; Annette F Baas; Corstiaan C Breugem; Karen Duran; Maarten Massink; Patrick W B Derksen; Wilfred F J van IJcken; Leontine van Unen; Fernando Santos-Simarro; Pablo Lapunzina; Vera L Gil-da Silva Lopes; Elaine Lustosa-Mendes; Max Krall; Anne Slavotinek; Victor Martinez-Glez; Jeroen Bakkers; Koen L I van Gassen; Annelies de Klein; Marie-José H van den Boogaard; Gijs van Haaften
Journal:  Eur J Hum Genet       Date:  2018-01-18       Impact factor: 4.246

7.  Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.

Authors:  Max A K Rätze; Thijs Koorman; Thijmen Sijnesael; Blessing Bassey-Archibong; Robert van de Ven; Lotte Enserink; Daan Visser; Sridevi Jaksani; Ignacio Viciano; Elvira R M Bakker; François Richard; Andrew Tutt; Lynda O'Leary; Amanda Fitzpatrick; Pere Roca-Cusachs; Paul J van Diest; Christine Desmedt; Juliet M Daniel; Clare M Isacke; Patrick W B Derksen
Journal:  Oncogene       Date:  2022-04-18       Impact factor: 8.756

8.  Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma.

Authors:  Nilgun Tasdemir; Kai Ding; Laura Savariau; Kevin M Levine; Tian Du; Ashuvinee Elangovan; Emily A Bossart; Adrian V Lee; Nancy E Davidson; Steffi Oesterreich
Journal:  Sci Rep       Date:  2020-07-13       Impact factor: 4.379

9.  Association of genetic variants of FBXO32 and FOXO6 in the FOXO pathway with breast cancer risk.

Authors:  Haijiao Wang; Hongliang Liu; Lingling Zhao; Sheng Luo; Tomi Akinyemiju; Shelley Hwang; Ying Yue; Qingyi Wei
Journal:  Mol Carcinog       Date:  2021-07-01       Impact factor: 5.139

10.  αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.

Authors:  Jolien S de Groot; Max Ak Ratze; Miranda van Amersfoort; Tanja Eisemann; Eva J Vlug; Mijanou T Niklaas; Suet-Feung Chin; Carlos Caldas; Paul J van Diest; Jos Jonkers; Johan de Rooij; Patrick Wb Derksen
Journal:  J Pathol       Date:  2018-06-20       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.